news

FDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administration (FDA) has granted Accutar Biotechnology’s Investigational New Drug (IND) application for Phase I clinical trial of AC0176 for treating metastatic castration-resistant prostate cancer (mCRPC). An i...

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Cerner Corporation entered into an agreement as per which Oracle will acquire Cerner through an all-cash tender offer for approximately USD 28.3 billion in equity value.  Larry Ellison, Chairman and C...

Biogen-Eisai's potential Aduhelm sequel drug secured speedy review by FDA Biogen and Eisai’s Alzheimer’s disease treatment-in-waiting, lecanemab, has been secured a fast-track tag by the FDA, setting up a potentially swift path through the regulatory process. The drug is the next in line behind the pair’s app...

Sky receives FDA clearance to market the geko™ device for venous insufficiency and ischemia  On December 16, 2021, Sky Medical Technology Ltd, a medical device company, got approval from the US Food and Drug Administration (FDA) 510(k) to market the geko™ device for growing microcirculatory bl...

First patient enrolled in BrainQ's Pivotal Trial, EMAGINE™, for frequency-tuned electromagnetic field therapy to reduce disability following Ischemic Stroke   On December 09, 2021, BrainQ announced the enrollment of the first patient at MedStar National Rehabilitation Hospital in its pivotal, randomized, ...

Pfizer acquires drugmaker Arena for USD 6.7 billion to address unmet needs Pfizer declared that it is acquiring Arena Pharmaceuticals, a drug company specializing in inflammation and immunology, for almost USD 7 billion. The pharma giant said it would finance the agreement, worth USD 6.7 billion, with cash on ha...

Boston Scientific initiates trial to evaluate industry's first Modular CRM System  On December 02, 2021, Boston Scientific Corporation started the MODULAR ATP clinical trial to examine the safety, performance, and effectiveness of the mCRM™ Modular Therapy System. The system comprises of two cardiac ...

Aslan Pharmaceuticals enters into a strategic collaboration with IQVIA   ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organisation for log...

Canon Medical launches super-resolution deep-learning reconstruction for Cardiac CT scans  On November 28, 2021, Canon Medical launched the Precise IQ Engine (PIQE) DLR and SilverBeam filter in the recent version of the Aquilion ONE / PRISM edition. PIQE, super-resolution deep-learning reconstruction techno...

GE Healthcare, Optellum collaborate for AI-based lung cancer diagnosis GE Healthcare has collaborated with Optellum to progress precision diagnosis and lung cancer treatment with artificial intelligence. The partnership is zeroed in on helping healthcare providers to evaluate the malignancy of a lung nodule a...